The pharmaceutical industry in India has witnessed remarkable growth over the past few decades, emerging as one of the world’s largest producers of generic medicines. One of the driving forces behind this growth is third-party or contract manufacturing, a business model that allows companies to outsource the production of medicines to specialized manufacturers. This approach not only optimizes operational costs but also enhances efficiency, quality, and scalability.